Subventions financées

Does SARS-CoV-2 infection increase cognitive decline via myelin loss in older individuals?

The MIND Platform is a groundbreaking initiative that will revolutionize brain research by allowing scientists to capture and analyze unprecedented detailed images of the brain at both large and small scales.

Systems neuroscience owes much of its success to an empirical tradition of using simplified laboratory settings that carefully control sensory stimuli, motor responses, or other task-relevant variables in order to identify the neural mechanisms underlying different behavioral functions.

Alzheimer’s Disease (AD) affects many people and leads to memory loss and cognitive decline. It is linked to brain inflammation and changes in proteins like GFAP, which is usually found in support cells called astrocytes.

While it is the immune system that damages the brain in MS, the way this damage is caused involves many processes.

A type of brain cancers called “diffuse gliomas” currently lacks effective treatments.

The SLEEP HUB is an innovative platform aimed at advancing sleep research and fostering collaborations at various levels—local, national, and international.

ALS is a devastatingly fatal neurodegenerative disease with patients losing their ability to walk, talk, eat, and interact with their loved ones.

A hallmark and the earliest event taking place in ALS is the denervation of neuromuscular junctions (NMJs), which results in muscle weakness and paralysis.

ALS is a devastating neurological disease characterized by the progressive degeneration of motor neurons leading to paralysis and death.